Population

64 adult women with chronic telogen effluvium, randomized into 2 parallel groups (application of NEOPTIDE Expert [n= 32] versus no application [n= 32]) / Centre de santé Sabouraud (Dr. Pascal Reygagne)
Positive vertex pull test (≥10% hair removed) 
 

Application of NEOPTIDE Expert anti-hair loss growth serum

Application once a day to the scalp for 16 weeks

Evaluation criteria

Primary endpoint: Tolerance

• Skin tolerance under dermatological control after 4, 8, 12 and 16 weeks of application

Secondary endpoints: Efficacy

• Primary efficacy endpoint: anti-hair loss efficacy using the vertex pull test
• Secondary efficacy endpoints: 
  • Anti-hair loss efficacy by the 60' hair count test
  • Anti-hair loss efficacy and on hair quality perceived by the patients
  • Impact on quality of life
     

Results

• Significant decrease in the number of hairs collected during the pull test and the 60' hair count test from the first month

• Significant improvement in hair density and volume from the first month

• Significant reduction in discomfort related to hair loss of -41% and its impact on social life of -37% after 2 months, significantly greater than for the control group
• Very good skin tolerance

Conclusion

• Very good skin tolerance
• Significant reduction in hair loss from the first month
• Significant improvement in hair quality from the first month
• Significant effect on the psychological impact of hair loss